This study is not the major mover. It’s the Illucix for prostate cancer that is more important. 24/9 is when we will hear if US FDA approves its use. Then UK/Europe, Canada and Australia come next.
This study is not the major mover. It’s the Illucix for prostate...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.99 |
Change
-0.480(2.05%) |
Mkt cap ! $7.662B | |||
| Open | High | Low | Value | Volume |
| $23.25 | $23.36 | $22.78 | $20.65M | 898.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1012 | $25.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.70 | 32 | 2 |
View Market Depth
| Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |